Our treatments section provides information on the medical areas included in our ongoing clinical research. Here, you can explore a range of conditions and topics currently under scientific investigation, with background summaries informed by peer-reviewed literature and ongoing studies. The content aims to offer a clear overview of the focus areas we examine, supporting a broader understanding of the science behind our research.
This clinical trial investigates the potential of MSCs in prevention of cardiovascular disease and follows several longevity and disease biomarkers. Cardiovascular disease is the leading cause of death globally, taking an estimated 20 million lives each year. Prevention is a proactive approach to healthcare that seeks to maintain health and prevent development of illness.
You may be eligible if you:
Musculoskeletal injuries and degeneration may occur for various reasons, such as accidents, sports injuries, genetics, or just wear and tear. Depending on your condition you may be eligible for local and/or systemic treatment.
You may be eligible if you are 18 years or older and have:
The geriatric syndrome of frailty is a common clinical syndrome based on the accumulation of multi-systemic function declines and the increase in susceptibility to stressors during biological ageing. This can manifest in a variety of symptoms, such as decreased muscle strength, reduced mobility, and impaired cognitive function. Frailty can also increase an elderly persons risk of falls, hospitalization, and other negative health outcomes.
You may be eligible if you:
Osteoarthritis (OA) is the most common form of arthritis and is also known as degenerative arthritis and OA. It occurs most frequently in the hands, hips, and knees. A common symptom of OA is a stiff and painful feeling around the joints.
Please note that this is not a separate trial. Treatments for OA will be included in the musculoskeletal injuries and degeneration trial.
